In Frontiers in public health
Coronavirus Disease 2019 (COVID-19) is currently a global pandemic, and early screening is one of the key factors for COVID-19 control and treatment. Here, we developed and validated chest CT-based imaging biomarkers for COVID-19 patient screening from two independent hospitals with 419 patients. We identified the vasculature-like signals from CT images and found that, compared to healthy and community acquired pneumonia (CAP) patients, COVID-19 patients display a significantly higher abundance of these signals. Furthermore, unsupervised feature learning led to the discovery of clinical-relevant imaging biomarkers from the vasculature-like signals for accurate and sensitive COVID-19 screening that have been double-blindly validated in an independent hospital (sensitivity: 0.941, specificity: 0.920, AUC: 0.971, accuracy 0.931, F1 score: 0.929). Our findings could open a new avenue to assist screening of COVID-19 patients.
Liu Xiao-Ping, Yang Xu, Xiong Miao, Mao Xuanyu, Jin Xiaoqing, Li Zhiqiang, Zhou Shuang, Chang Hang
2022
Coronavirus Disease 2019 (COVID-19), artificial intelligence, biomedical imaging application, chest CT image, imaging biomarker, multicentric retrospective study
